ASHLEY HENSON: Open Payments
NPI 1144669649 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 172 payments from 26 companies in 2025. Trend: 2023 $2,037 · 2024 $3,088 · 2025 $3,441
Food & beverage: $3,441
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $581 |
| GlaxoSmithKline, LLC. | 35 | $454 |
| Regeneron Healthcare Solutions, Inc. | 11 | $258 |
| HARMONY BIOSCIENCES LLC | 9 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $224 |
| Merck Sharp & Dohme LLC | 9 | $197 |
| Verona Pharma, Inc. | 9 | $154 |
| Electromed, Inc. | 7 | $140 |
| GENZYME CORPORATION | 5 | $124 |
| Actelion Pharmaceuticals US, Inc. | 7 | $124 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, WAKIX, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, SMARTVEST.
Industry payments across MS — which companies pay providers there.
